scholarly journals Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study

2015 ◽  
Vol 13 ◽  
pp. 13-17 ◽  
Author(s):  
Ashley S. Felix ◽  
Kristen Bunch ◽  
Hannah P. Yang ◽  
Hannah Arem ◽  
Britton Trabert ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Hormone Therapy ◽  
Menopausal Hormone Therapy ◽  
Health Study

scholarly journals Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study

2012 ◽  
Vol 107 (7) ◽  
pp. 1181-1187 ◽  
Author(s):  
B Trabert ◽  
N Wentzensen ◽  
H P Yang ◽  
M E Sherman ◽  
A Hollenbeck ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Hormone Therapy ◽  
Menopausal Hormone Therapy ◽  
Health Study

scholarly journals Menopausal Hormone Therapy and Ovarian Cancer Risk in the National Institutes of Health–AARP Diet and Health Study Cohort

2006 ◽  
Vol 98 (19) ◽  
pp. 1397-1405 ◽  
Author(s):  
James V. Lacey ◽  
Louise A. Brinton ◽  
Michael F. Leitzmann ◽  
Traci Mouw ◽  
Albert Hollenbeck ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Risk ◽  
Hormone Therapy ◽  
Menopausal Hormone Therapy ◽  
National Institutes Of Health ◽  
Health Study ◽  
Study Cohort ◽  
Ovarian Cancer Risk

scholarly journals Menopausal hormone therapy and mortality among endometrial cancer patients in the NIH-AARP Diet and Health Study

2015 ◽  
Vol 26 (8) ◽  
pp. 1055-1063 ◽  
Author(s):  
Ashley S. Felix ◽  
Hannah Arem ◽  
Britton Trabert ◽  
Gretchen L. Gierach ◽  
Yikyung Park ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Hormone Therapy ◽  
Cancer Patients ◽  
Menopausal Hormone Therapy ◽  
Health Study

Menopausal hormone therapy and ovarian cancer: Putting risk into perspective

Maturitas ◽  
2015 ◽  
Vol 81 (1) ◽  
pp. 3-4 ◽  
Author(s):  
Faustino R. Pérez-López ◽  
Margaret Rees
Keyword(s):  
Ovarian Cancer ◽  
Hormone Therapy ◽  
Menopausal Hormone Therapy

Menopausal Hormone Therapy and Risk of Epithelial Ovarian Cancer

2007 ◽  
Vol 16 (12) ◽  
pp. 2548-2556 ◽  
Author(s):  
M. A. Rossing ◽  
K. L. Cushing-Haugen ◽  
K. G. Wicklund ◽  
J. A. Doherty ◽  
N. S. Weiss
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Hormone Therapy ◽  
Menopausal Hormone Therapy

Review Article: Sexuality and Risk-Reducing Salpingo-oophorectomy

2017 ◽  
Vol 27 (4) ◽  
pp. 847-852 ◽  
Author(s):  
Paige E. Tucker ◽  
Paul A. Cohen
Keyword(s):  
Ovarian Cancer ◽  
Hormone Therapy ◽  
Familial Cancer ◽  
Safety Data ◽  
Well Being ◽  
Menopausal Hormone Therapy ◽  
Brca1 And Brca2 ◽  
Sexual Symptoms ◽  
Increased Risk ◽  
Risk Reducing

IntroductionWomen with familial cancer syndromes such as hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2) and Lynch syndrome are at a significantly increased risk of developing ovarian cancer and are advised to undergo prophylactic removal of their ovaries and fallopian tubes at age 35 to 40 years, after childbearing is complete.MethodsA comprehensive literature search of studies on risk-reducing salpingo-oophorectomy (RRSO), sexuality, and associated issues was conducted in MEDLINE databases.ResultsRisk-reducing salpingo-oophorectomy can significantly impact on a woman’s psychological and sexual well-being, with women wishing they had received more information about this prior to undergoing surgery. The most commonly reported sexual symptoms experienced are vaginal dryness and reduced libido. Women who are premenopausal at the time of surgery may experience a greater decline in sexual function, with menopausal hormone therapy improving but not alleviating sexual symptoms. Pharmacological treatments including testosterone patches and flibanserin are available but have limited safety data in this group.ConclusionsDespite the high rates of sexual difficulties after RRSO, patient satisfaction with the decision to undergo surgery remains high. Preoperative counseling with women who are considering RRSO should include discussion of its potential sexual effects and the limitations of menopausal hormone therapy in managing symptoms of surgical menopause.

scholarly journals Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH–AARP Diet and Health Study Cohort

2012 ◽  
Vol 23 (3) ◽  
pp. 487-496 ◽  
Author(s):  
Louise A. Brinton ◽  
Lauren Schwartz ◽  
Margaret R. Spitz ◽  
Yikyung Park ◽  
Albert R. Hollenbeck ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Risk ◽  
Hormone Therapy ◽  
Lung Cancer Risk ◽  
Menopausal Hormone Therapy ◽  
Health Study ◽  
Study Cohort ◽  
Unopposed Estrogen ◽  
Estrogen Plus Progestin

scholarly journals Menopausal Hormone Therapy and Breast Cancer Risk in the NIH-AARP Diet and Health Study Cohort

2008 ◽  
Vol 17 (11) ◽  
pp. 3150-3160 ◽  
Author(s):  
Louise A. Brinton ◽  
Douglas Richesson ◽  
Michael F. Leitzmann ◽  
Gretchen L. Gierach ◽  
Arthur Schatzkin ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Risk ◽  
Cancer Risk ◽  
Hormone Therapy ◽  
Menopausal Hormone Therapy ◽  
Health Study ◽  
Study Cohort
Sign in / Sign up

Export Citation Format

Share Document